Jason A Efstathiou - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jason A Efstathiou

Showing results (91-100 of 278) with videos related to

Pageof 28

Sort By:

Clinical Genitourinary Cancer|April 11, 2021

Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerTrevor J Royce, Yuan Liu, Matthew I Milowsky, et al.

Clinical Genitourinary Cancer|November 29, 2018

Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder CancerTrevor J Royce, Adam S Feldman, Matthew Mossanen, et al.

JAMA Network Open|May 16, 2022

Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific MortalityLaura Burgess, Christopher M Aldrighetti, Anushka Ghosh, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.

International Journal of Radiation Oncology, Biology, Physics|April 8, 2011

Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysisJohn J Coen, Anthony L Zietman, Carl J Rossi, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008

Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02Matthew R Smith, Kyounghwa Bae, Jason A Efstathiou, et al.

Cancer|November 14, 2007

Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.

Current Urology Reports|January 24, 2013

Trimodality therapy for bladder conservation in treatment of invasive bladder cancerTimur Mitin, William U Shipley, Jason A Efstathiou, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009

Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.

Practical Radiation Oncology|June 28, 2016

Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012Jonathan J Paly, Chun Chieh Lin, Phillip J Gray, et al.

Pageof 28

Search research articles

Showing results (91-100 of 278) with videos related to

Sort By:

Pageof 28

Clinical Genitourinary Cancer|April 11, 2021

Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerTrevor J Royce, Yuan Liu, Matthew I Milowsky, et al.

Clinical Genitourinary Cancer|November 29, 2018

Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder CancerTrevor J Royce, Adam S Feldman, Matthew Mossanen, et al.

JAMA Network Open|May 16, 2022

Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific MortalityLaura Burgess, Christopher M Aldrighetti, Anushka Ghosh, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.

International Journal of Radiation Oncology, Biology, Physics|April 8, 2011

Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysisJohn J Coen, Anthony L Zietman, Carl J Rossi, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008

Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02Matthew R Smith, Kyounghwa Bae, Jason A Efstathiou, et al.

Cancer|November 14, 2007

Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.

Current Urology Reports|January 24, 2013

Trimodality therapy for bladder conservation in treatment of invasive bladder cancerTimur Mitin, William U Shipley, Jason A Efstathiou, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009

Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.

Practical Radiation Oncology|June 28, 2016

Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012Jonathan J Paly, Chun Chieh Lin, Phillip J Gray, et al.

Pageof 28